Human Resources
HR leaders from Sanofi and Cardinal Health reveal the future of work in the pharma and medtech sectors

Human Resources: Forces of change are impacting three major dimensions of work: the work itself, who does the work, and where work is done. It’s important to consider multiple trends and how they are changing all aspects of work, with implications for individuals, businesses and society.
Michelle Zimany, Director, Human Resources ANZ at Sanofi and Farrukh Ahmad, HRBP Manager at Cardinal Health ANZ joined Health Industry Hub to discuss the trends driving the evolution of work, workforces and workplaces in the pharma and medtech sectors.
The pandemic has strained and tested the worker-employer relationship beyond anyone’s anticipation. Michelle and Farrukh reflected on how the worker-employer relationship has evolved, and which factors have the greatest influence on the relationship moving forward.
‘Manager quality’ still remains the top reason Australian employees are leaving their workplace. In an employment market that is currently favouring job seekers, Michelle and Farrukh revealed the key challenges that leaders need to overcome to foster the right culture in retaining their staff.
Companies have also started investing in ‘future of work’ initiatives. These HR leaders from the pharma and medtech sectors shared their views on how employers can make the future of work more valuable and meaningful for the multigenerational workforce, leaders and the business.

Hunton Executive is the proud supporter of this interview. Hunton Executive is an executive search and organisational consulting firm dedicated to the success of the global life science and healthcare senior and executive workforce.
News - MedTech & Diagnostics
PL reforms deliver $1 billion in savings but patients are yet to see the benefit
The final evaluation of the Prescribed List (PL) reforms has delivered a mixed verdict on one of the private health […]
MoreNews - Pharmaceuticals
Lilly global CEO takes aim at PBS over Mounjaro price fight
Eli Lilly’s global CEO has accused the Pharmaceutical Benefits Scheme (PBS) of failing to keep pace with a new era […]
MoreNews - Pharmaceuticals
Cheap old drug enters MS PBS review as access battle continues
The Department of Health has outlined the scope and timelines of the Rapid review of PBS medicines for relapsing-remitting multiple […]
MoreNews - MedTech & Diagnostics
The piss test, missed diagnoses and the dialysis crunch: Kidney Action Week
Kidney Health Australia is taking an unconventional approach to a serious health issue, launching a national media campaign during Kidney […]
More